Bavarian State Minister of Health and Care
Director of the Cardiology Department, German Heart Centre Munich
Heribert Schunkert, MD is Professor of Cardiology of the Technische Universität München and Director of the Cardiology Department, German Heart Centre Munich since 2012. He completed a research fellowship at Brigham and Women’s Hospital, Boston, USA and clinical fellowships at Beth Israel Hospital, Universitätsklinikum Regensburg, and the Massachusetts General Hospital, Boston, USA, before he became assistant and associate professor in Regensburg. From 2002-2012 Prof. Schunkert was Director of Internal Medicine and Cardiology at the University of Luebeck. He conducts research in the molecular genetics of multifactorial cardiovascular disease, coordinates several EU- and BMBF-sponsored projects as well as the European-American Leducq network CADgenomics to identify the genetic roots of myocardial infarction. He is the author of more than 700 publications in international journals.
Managing Director BioM Biotech Cluster Development GmbH
After earning his doctorate in biochemistry in 1979, Horst Domdey worked as a scientist at various German, Swiss and US institutes such as the Max Planck Institute of Biochemistry, the ISREC, the UCSD and the California Institute of Technology. From 1984 to 1994 he headed an independent research group at the Gene Center of the LMU Munich where he was appointed Professor of Biochemistry in 1994. In the same year he co-founded MediGene, one of the first German biotech companies. In 1996 he successfully led the Munich Biotech Initiative into the German BioRegio Competition. Since 1997 he has been the Managing Director of BioM, the cluster development and management organization of the Munich Biotech Cluster. Since 2006 he also oversees the Bavarian Biotechnology Network. From 2010 to 2015, he was the spokesman of the Munich leading edge cluster program m4 – Personalized Medicine m4. Among others he is member of the Supervisory Board of Medigene AG, of the Advisory Board of GNA Biosolutions, of the boards of the Peter and Traudl Engelhorn Foundation and the Foundation for Stem Cell Research and Applied Regenerative Medicine, of the Advisory Board of FCF Fox Corporate Finance, and of the Translational Research Group of the German Centre for Cardiovascular Research.
Senior Counsel Pharmaceutical Law, Verband Forschender Arzneimittelhersteller e.V.
Henning Düwert joined vfa in 2010 as a Counsel specialized in Pharmaceutical and Data Protection Law. He is responsible for the Data Protection topics within vfa. He is a member of national as well as international working groups dealing with digitization in health care. Before joining vfa Henning Düwert worked in different law firms.
Managing Director DigiMed Bayern: BioM Biotech Cluster Development
Jens joined BioM in early 2018 to help setting up the Bavarian P4 medicine flagship project DigiMed Bayern. Since it’s start he is heading DigiMed Bayern operational part as Managing Director. The project aims to implement digitally driven predictive, preventive, personalized and participatory medicine of the future in the examplary field of atherosclerotic diseases. It is funded by the Bavarian State Ministry of Health and Care with a total of above € 24 Mio with runtime until 2024.
In addition, Jens supports BioM and the Bavarian Biotech Cluster with his expertise in international Business Development and Digital Health.
2006 to 2018 he was responsible for setting up and scaling DNA-related services within different companies of the Eurofins group. This comprised DNA-Forensics, ancestry and paternity testing as well as animal and plant breeding, food analysis and cell genotyping. 2001 to 2006 he worked in Sales and Product Management for the Munich area based SME Biomax Informatics AG.
Jens has a PhD in Protein Engineering from the Gene Center of the Ludwig Maximilian University of Munich and a Diploma in Biology (Population Genetics) from Christian-Albrechts-Universität zu Kiel.
Ludwig-Maximilians-University, Institut Technik-Theologie-Naturwissenschaften
Machine Learning and Data Analytics (MaD) Lab, Friedrich-Alexander-University Erlangen-Nürnberg
Bjoern M. Eskofier heads the Machine Learning and Data Analytics (MaD) Lab at the Friedrich-Alexander-University Erlangen-Nuernberg (FAU). He is also the current speaker of FAU’s Department Artificial Intelligence in Biomedical Engineering (AIBE) and of the German Ministry of Economic Affairs and Climate Action GAIA-X usecase project “TEAM-X” and the co-speaker of the German Research Foundation collaborative research center “EmpkinS” (SFB 1483).
Dr. Eskofier studied Electrical Engineering at the FAU and graduated in 2006. He then studied under the supervision of Prof. Dr. Benno Nigg at the University of Calgary (Canada). He authored more than 300 peer reviewed articles, submitted 7 patent applications, started three spinoff startup companies, and is in a supporting role for further startups. He won several medical-technical research awards, including the “Curious Minds” award in “Life Sciences” by Manager Magazin and Merck. In 2016, he was a visiting professor in Dr. Paolo Bonato’s Motion Analysis Lab at Harvard Medical School (February-March), and in 2018, he was a visiting professor in Dr. Alex “Sandy” Pentland’s Human Dynamics group at MIT Media Lab (March-August).
Bjoern Eskofier has defined his research and entrepreneurial agenda to revolve around contributions to a “Digital Health Ecosystem”, where patients are connected to other stakeholders within the Healthcare system using digital support tools. His digital health research philosophy is that only multidisciplinary teams of engineers, medical experts, industry representatives and entrepreneurs will have the tools to actually implement changes in Healthcare.
Ludwig-Maximilians-University, Institut Technik-Theologie-Naturwissenschaften
Therese Feiler has been a Research Associate at the Chair of Systematic Theology and Ethics at LMU since 2019. As a member of the DigiMed Bayern consortium she deals with ethical questions regarding personalised and digitalised medicine. She focuses on political-theological and political-ethical aspects, as well as questions of rationale and fundamental concepts. In 2013, she completed her DPhil in Christian Ethics at the University of Oxford, where until 2018 she was a Wellcome Trust Postdoctoral Researcher in the Healthcare Values Partnership. Together with Arne Dreßler she is currently preparing a collected volume on the "We" in P4-medicine.
Director Gene Center Munich
Director Strategy and Standards, gematik GmbH
Stefan Höcherl joined gematik in April 2020 and he is Head of Strategy & Standards. He is responsible for strategic issues relating to corporate development as well as the topics of standardisation and the national coordination office for interoperability in the German healthcare system, as well as European cooperation in the area of digital health. Prior to this, Mr. Höcherl held various positions in the healthcare sector where he helped to shape future topics and worked as a consultant for an industry association as well as for strategy and public affairs consultancies with a focus on healthcare & digital pharma in Berlin.
Foto: © gematik_Jan Pauls
Head of Department 1, Bavarian State Ministry of Health and Care
Dr. Thomas Huber has been Ministerial Dirigent at the Bavarian State Ministry of Health and Care since April 2018. The lawyer heads the department “Coordination, Digitalization, Innovation, State Examination Office for Social Security”, where responsibilities for digital health and care are largely combined. In addition, there are cross-sectoral care and the health and care industry as a sector of the future with great potential for innovation and employment. Prior to that, Dr. Huber worked for a long time in many positions in the area of responsibility of the Bavarian State Ministry of the Interior and most recently in the Bavarian State Chancellery as Deputy Head of the Department for Policy Issues, Planning and Communication.
Workflow coordinator German Human Genome-Phenome Archive, Munich Data Science Institute, Technical University of Munich
Dr. Christian Mertes is the workflow workstream coordinator at the German Human Genome-Phenome Archive (GHGA) and a member of the Munich Data Science Institute (MDSI) at the Technical University of Munich (TUM). Within the GHGA, the German node of the federated European Genome-Phenome Archive (EGA), he is responsible for the development, standardization, and harmonization of next-generation sequencing (NGS) data processing. He is also involved in the establishment of the Munich node, one of the six evolving data hubs in Germany hosting and processing GHGA data.
Christian Mertes studied bioinformatics in Munich at TUM and Ludwig-Maximilians-University (LMU). He received his PhD in (bio)informatics in 2021 from the Department of Informatics at TUM while working in the chair of Computational Molecular Medicine. His focus was on statistical methods for finding outliers in RNA sequencing data to aid in the diagnosis of rare diseases. During his PhD, Christian Mertes co-developed OUTRIDER, a tool for detecting aberrant gene expression, FRASER, a tool for detecting aberrant splicing events, and DROP, an automated workflow for analyzing RNA-seq data to aid clinicians in diagnosis, which are now widely adopted by the rare disease community worldwide.
Director General, Danish Health Data Authority
Lisbeth Nielsen has been Director General at the Danish Health Data Authority since 2015. In her role as DG she is responsible for the use of health data in Denmark. The use of health data has a high strategic priority in a highly digitized and interconnected health care system. She comes from a background in both the public and the private sector. Before 2015, Lisbeth Nielsen worked as Chief Quality Officer at North Zealand Hospital, as Assistant Director at Danish regions and as a head of Health Care Sales at IBM. She is a Master of Public Administration from the University of Roskilde.
The Danish Health Data Authority works with three core tasks:
Health data and registers
By developing and running the national health registers, we ensure comprehensive and valid health data for patient treatment, development, planning and research. We provide health statistics and analyses of cause of death, disease patterns, medicine and activity in the healthcare sector etc. and monitor and follow up on political goals and agreements in terms of quality and efficiency in health.
We also develop, maintain and exhibit classifications and terminologies and give advice on the use.
Digital health solutions
We manage major projects and programmes that strengthen the coordination of digitalisation of the healthcare sector. We are responsible for IT solutions such as the National Service Platform, the Shared Medication Record and many other solutions that are used throughout the healthcare system.
By setting shared goals in the form of strategies, agreements and IT architecture, we coordinate the work with health data and IT across the Danish healthcare system.
Cyber and information security
We are responsible for facilitating and coordinating efforts to ensure cyber and information security within The Ministry of Health and the Danish healthcare sector in general.
Director of the Institute of Epidemiology, Helmholtz Zentrum München
Prof. Dr. Annette Peters is Director of the Institute of Epidemiology at Helmholtz Munich – German Research Center for Environmental Health and is full Professor of Epidemiology at the Ludwig Maximilians Universität München, Germany. She studied biology and mathematics in Germany and epidemiology at the Harvard School of Public Health, Boston, USA.
She has a long-standing interest in understanding the role of ambient air pollution in contributing to exacerbation and initiation of chronic diseases. Furthermore, she did pioneer work identifying the link between ambient particulate matter and cardiovascular disease.
Today, Peters heads the population-based KORA cohort initiated in the mid-eighties in Augsburg, Germany and funded by the German Ministry of Education and Research between 2008 and 2014. Following the first measurements in 1999, she has continuously grown the research program on environmental measurements for air pollution and other environmental exposures in the KORA study region.
Moreover, she is principal investigator of the German National Cohort, which investigates prospectively 205,000 men and women. She is responsible for building its central biorepository. Here, the goal is to implement a nation-wide beyond the state of the art large-scale epidemiological study including innovative biobanking for all members and magnet resonance tomography assessments for 30,000 participants. Peters research interest are age-related and chronic diseases. Specifically, she strives to improve the understanding of disease development by integrating lifestyle and environmental factors, molecular and imaging markers to assess their relative impact on cardiometabolic diseases. Finally yet importantly, she started additional data collecting in order to contribute to fighting the COVID-19 pandemic.
Researcher at the Technical University of Munich, Professorship for Digital Health and the University Hospital Bonn, Institute for Digital Medicine
Researcher at the Technical University of Munich, Professorship for Digital Health (since 2019) and the University Hospital Bonn, Institute for Digital Medicine (since 2021)
M.Sc. Information Systems at the Technical University of Munich, with specialization on software engineering for mobile applications
Current doctorate on Physical Activity Recognition using Mobile Devices, dissertation submitted in 06/2022
- Reimer, L. M., Kapsecker, M., Fukushima, T., & Jonas, S. M. (2022). Evaluating 3D Human Motion Capture on Mobile Devices. Applied Sciences, 12(10), 4806. https://doi.org/10.3390/app12104806
- Reimer, L. M., Starnecker, F., Schunkert, H., & Jonas, S. (2021). Developing an App for Cardiovascular Prevention and Scientific Data Collection. In D. Hayn, G. Schreier, & M. Baumgartner (Hrsg.), Studies in Health Technology and Informatics. IOS Press. https://doi.org/10.3233/SHTI210095
- Reimer, L. M., Weigel, S., Ehrenstorfer, F., Adikari, M., Birkle, W., & Jonas, S. (2021). Mobile Motion Tracking for Disease Prevention and Rehabilitation Using Apple ARKit. In D. Hayn, G. Schreier, & M. Baumgartner (Hrsg.), Studies in Health Technology and Informatics. IOS Press. https://doi.org/10.3233/SHTI210092
Cardiology Department, German Heart Centre Munich
Coordinator of the Vroni-Study (www.myvroni.de)
Since 2014 Residency at the German Heart Center, Munich, Department of Cardiology
Medical degree at Ludwig-Maximilians-University (LMU), Munich
Qualification for genetic counselling (Internal Medicine)
|2007-2013||Medical degree at Ludwig-Maximilians-University (LMU), Munich|
|2000-2005||Pädagogisches Gymnasium, Bozen (Italy)|
|2005||General qualification for university entrance (Matura)|
Residency at the German Heart Center, MunichDepartment of Cardiology
Selected fellowships and awards (if applicable)
|2012-2014||Academic excellence Scholarship by Autonome Provinz Südtirol|
|2012-2013||Practical Year in Medical School|
Institutional responsibilities (if applicable)
|2018||Member of Digimed Bayern, a pilot project in predictive, preventive, personalized and participatory (P4) medicine in Germany, funded by the Bavarian State Ministry of Health and Care.|
|2018||Study coordinator of the VRONI-Study-population based Screening for FH in children|
Selected further activities
|Qualification for genetic counselling (Internal Medicine)|
Cardiology Department, German Heart Centre Munich
• 2014 – current Resident for Internal Medicine and Cardiology, German Heart Center Munich (DHM) of the Technical University Munich, Germany, Medical Director Prof. Dr. H. Schunkert
• 2014 Surgery, Klinikum Rechts der Isar of the Technical University Munich, Germany
• 2014 Neurology, University Hospital of Zürich, Switzerland
• 2013 Pediatrics, University Hospital Großhadern, Munich, Germany
• 2013 Inner Medicine and Cardiology, University Hospital Großhadern, Munich, Germany
• 2013 Intensive-Care Medicine, University Hospital Großhadern, Munich, Germany
• 2013 General Medicine, AGZ, Altenmarkt, Austria
Research and work in progress
• 2015 – current Research on atherosclerosis – Supervisor and Medical Director Prof. Dr. H. Schunkert
• 2018 DZHK Clinician Scientist Programme – Identification and validation of key driver genes in atherosclerosis relevant networks.
• 2018 DigiMed Bayern. Scientific Co-PI: Multi-Omics in Atherosclerosis – approaching personalized medicine in CAD.
• 2016 Research fellow of the Departments of Medicine, Microbiology, Immunology, Molecular and Human Genetics, David Geffen School of Medicine, University of California Los Angeles, USA
• 2016 – 2018 “CADgenomics – Understanding CAD Genes programme” - supported by grants from the Fondation Leducq
• 2011 – 2014 Research fellow of the transplant-immunologic research laboratory Innsbruck, Austria Department of Visceral-, Transplant- and Thoracic-Surgery, University of Innsbruck,
von Scheidt M, Zhao Y, de Aguiar Vallim TQ, Che N, Franzén O, Kurt Z, Yamamoto M, Edwards PA, Kovacic J, Björkegren J, Lusis AJ, Yang X, Schunkert H. The transcription factor MAFF regulates an atherosclerosis relevant gene network. Accepted at Circulation
Schunkert H, Boening A, von Scheidt M, […] Hambrecht R, Kastrati A, Sandner S. Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial. European Heart Journal. 2019 May 30. pii
von Scheidt M, Zhao Y, Kurt Z, Pan C, Zeng L, Yang X, Schunkert H, Lusis AJ. Applications and Limitations of Mouse Models for Understanding Human Atherosclerosis. Cell Metabolism. 2017 Feb 7;25(2):248-261.
Ambassador for Health and Wellbeing, Ministry for Foreign Affairs of Finland
Päivi Sillanaukee (MD, PhD, eMBA) is the thematic Ambassador for Health and Wellbeing at the Ministry for Foreign Affairs of Finland.
Dr Sillanaukee is on leave from her duty as the Director-General of the Department of Safety, Security and Health of the Ministry of Social Affairs and Health of Finland. Dr Sillanaukee served as the Permanent Secretary of the Ministry from 2012 to 2019. Between 2008 and 2012, she was the Director General of the Department for Social and Health Services at the Ministry. Previously, she was the Deputy Mayor and Director of Social and Health Services in the City of Tampere, Finland.
Between 1990 and 2004, she held clinical and managerial positions in the Pirkanmaa Hospital District and was a member of the Tampere City Council. Dr Sillanaukee is a specialist in public health and management and an honorary doctor in Medical Faculty from University of Helsinki. She is promoting and working on policies regarding public health, social protection, gender equality, innovation and digitalization in the European Union and at the global level. She holds a qualification from The Finnish Chamber of Commerce CBM, as a certified member of the Board.
She has represented Finland in the WHO Executive Board from May 2018 to May 2021 and served as its first and third Vice Chair from 2018 to 2020. She has served as Executive President at EUR/RC71 September 2021 and at the Special session of the Regional Committee May 2022. She is the co-chair of the Alliance for Health Security Cooperation (AHSC), a member of the Steering Group of the Global Health Security Agenda (GHSA), a member of Health Advisory Board of the UN Global Pulse Finland, a Member of the HIMSS Board of Directors and a Member of I-DAIR Board.
Cardiology Department, German Heart Centre Munich
Since 2018 Cardiology Residency at the German Heart Centre Munich, Department of Cardiology
Medical degree at Medical School of the Technical University Munich, with trainings and stays at the University Hospital Zurich, Switzerland; New York Presbyterian Hospital, Weill Cornell Medical College, USA; German Heart Centre Munich, Germany and Rotkreuzklinikum München, Germany
Health Tech and Operations Lead, AWS International Public Sector Healthcare
Joanna Wardzinski is the Health Tech and Operations Lead for AWS International Public Sector Healthcare (IPSH) partnering with Health ISVs to extend their success with AWS across borders, and leading a Health Tech Governance Program. She also leads a team responsible for operations across IPSH (e.g. budget, internal communications).
She started with AWS in 2017 covering strategic planning and investments across AWS EMEA Public Sector, then moved into building out the foundations for the healthcare vertical internationally. She has been in the digital technology field since 2014, leveraging her INSEAD MBA as a launch pad to a career dedicated to Tech for Good.
Joanna has also held positions at Microsoft, and with the Canadian federal government working on initiatives ranging from amendments to the Investment Canada Act to Commercial Missions to India. Joanna is a dual citizen of Canada and Poland, has lived in 7 different countries, and currently resides in Germany.
Outside work she enjoys spending time with her family (usually at a Trampoline Park, a Biergarten, or in the Bavarian Alps).
Managed by BioM Biotech Cluster Development GmbH
Copyright © 2022 BioM Biotech Cluster Development GmbH
Alle Rechte vorbehalten